2Robbins KT. Pocket guide to neck dissection classification and TNM staging of head and neck cancer[M]. Washington DC: American Academy of Otolaryngology-Head and Neck Surgery Foundation, Inc, and American Society for Head and Neck Surgery, 1991.
3Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging manual, 6th ed[M]. New York: Springer-Verlag, 2002. 18.
5Wang RJ, Rinaldo A, Ferlito A, et al. Occult cervical metastasis in head and neck cancer and its impact on therapy[J]. Acta Otolaryngol, 2002, 122:107-114.
6Woolgar JA. Pathology of the NO neck[ J]. Br J Oral Maxillofac Surg, 1999, 37:205-209.
7Woolgar JA. Micrometastases in oral/oropharyngeal squamous cell carcinoma: incidence, histopathological features and clinical implications[J]. Br J Oral Maxillofac Surg, 1999,37:181-186.
8Van den Brekel MWM, Van der waal I, Meijer CJLM, et al.The incidence of micrometastases in neck dissction specimens obtained from election neck diseection [ J]. Laryngoscope,1996, 106:987-991.
3[5]Bitran JD,Ultaman JE.Tumors of unknow origin[J].CA Cancer J Clin,1992,42(2):96.
4Haagensen CD, Feid CR, Herter FP, et al. The lymphatics in cancer. Philadelphia :WB Saunders Co, 1972. 59-86.
5Robbin KT. Pocket guide to neck dissection classification and TNM staging of head and neck cancer. Alexandria, American Academy of Otolaryngology-Head and Neck Surgery Foundation. Inc, 1991:9-20.
6Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging manul. 6th ed. New York: Spring-Verlag, 2002.18.
7Pitman KT, Johnson JT, Myers EN. Effectiveness of selective neck dissection for management of the clinically negative neck. Arch Otolaryngol Head Neck Surg, 1997,123:917-922.
8Coster JR, Foote RL, Csen KD, et al. Cervical nodal metastasis of squamous cell carcinoma of unknow originindication for withholding radiation therapy[J].Imermitional journal of Radiation Oncology Biology physics, 1992,23:743～749
9Reddy SP,Marks Jz, Metastatic carcinoma in the cervical lymph nodes from an unknow primary site:results of bilateral neck plus mucosal irradiation vs, ipsilateral neck irradiafion Iht J. Radiat Oncol Biol phys,1997,37:797～ 802
10Talmi YP, Wolf GT, Hazuka M, et al, Unknow priary of the head and neck[J].J larynol 0to1,1996,16(1):353-356
6Sakai O,Curtin HD,Romo LV,et al. Lymph node pathology. Benign proliferative,lymphoma, and metastatic disease [J].Radiol Clin North Am,2000,38(5):979-988.
7Su YC, Hsu YC, Chai CY. Role of TrF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung ade- nocarcinoma[J]. Kaohsiung JM Sci, 2006, 22(1): 14-19.
8Vang R, Gown AM, Wu IS, et al. Immunohistochemieal expression of CDX2 in primary ovarian Mucinous tumors and metastatic mu- cinous carcinomas in volving the ovary:comparison with CK20 and correlation With coordinate expnmsion of CK7[J].Mod Pathol, 2006, 19(11): 1421-1428.
9Park SY, Kim HS, Hong EK, et al. Expression of eytokeratins 7 and 20 in primary eareitmmas of the stomach and col rectum and their value in the differential diagnosis of metastatic carcinomas to the ovary [J]. Hum Pathol, 2002, 33(11): 1078-1085.
10Rubin BP, Skarin AT, Pisick E, et al. Use of eytokeratins7 and 20 in determini g the origin of metastatic carcinoma of unknown primary, with special emphasis onlung cancer[J]. EurJ Cancer Prey, 2001, 10(1): 77-82.
